Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 14 $ 799,732 $ (1,672,891) $ (873,145)
Balance at the beginning (in shares) at Dec. 31, 2019 142,369      
Fair value of warrants issued with convertible note   213,828   213,828
Share-based compensation   1,030,802   1,030,802
Net loss     (3,867,984) (3,867,984)
Balance at the end at Dec. 31, 2020 $ 14 2,044,362 (5,540,875) $ (3,496,499)
Balance at the end (in shares) at Dec. 31, 2020 142,369     142,369
Exchange of common shares of Marpai Health, Inc. (see Note 1) $ (14)     $ (14)
Exchange of common shares of Marpai Health, Inc. (in shares) (142,369)      
Issuance of common shares of Marpai, Inc. (see Note 1) (1) $ 1,115 17,350,820   17,351,935
Issuance of common shares of Marpai, Inc. (in shares) 11,147,301      
Issuance of common shares in connection with initial public offering, net $ 718 24,546,367   24,547,085
Issuance of common shares in connection with initial public offering, net (in shares) 7,187,500      
Conversion of convertible notes to common stock in connection with initial public offering $ 171 5,106,383   5,106,554
Conversion of convertible notes to common stock in connection with initial public offering (in shares) 1,712,162      
Exercise of warrant $ 23 899,977   900,000
Exercise of warrant (in shares) 225,000      
Exercise of Stock options $ 3 58   61
Exercise of Stock options (in shares) 27,763      
Stock options exercised (in shares) 27,763      
Fair value of warrants issued with convertible note   53,333   53,333
Share-based compensation   1,230,792   1,230,792
Net loss     (15,984,835) (15,984,835)
Balance at the end at Dec. 31, 2021 $ 2,030 $ 51,232,092 $ (21,525,710) $ 29,708,412
Balance at the end (in shares) at Dec. 31, 2021 20,299,726     20,299,727